🇺🇸 FDA
Patent

US 12186368

Compositions and methods for treatment of protease mediated disease

granted A61KA61K38/10A61K38/12

Quick answer

US patent 12186368 (Compositions and methods for treatment of protease mediated disease) held by The Regents of the University of California expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K38/10, A61K38/12, A61K38/1729, A61K38/55